mRNA Vaccines Market to be dominated by the Non-COVID-19 rRNA Vaccine through 2028
Rising incidence of chronic and infectious diseases is
expected to drive the growth of Global
mRNA Vaccine Market in the forecast period.
According to TechSci Research report, “mRNA Vaccines Market –Industry
Size, Share, Trends, Opportunity, and Forecast, 2018-2028”, Global mRNA
Vaccines Market seen the highest growth during the COVID years,
2020-2021. 2020 was a breakout year for mRNA technology platforms with the
launch and widespread use of mRNA vaccines for COVID-19.
The market is
expected to witness significant growth in the forecasted years also due to the growing
research activities on the development of mRNA Vaccines for various communicable
and non-communicable diseases such as cancer, HIV, influenza, kidney problems,
among others. Globally, around 38.4 million people were living with HIV in
2021. 54% of all people living with HIV were women and girls. Around 1.5
million people became newly infected with HIV in 2021. About 650,000 people
died from AIDS-related illnesses in 2021.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global mRNA Vaccines Market"
Global mRNA Vaccines
Market can be segmented by
mRNA type, by application, and by region.
Global mRNA
Vaccines Market can be divided into three categories: Nucleoside-modified mRNA,
Unmodified mRNA, Self-Amplifying mRNA. The drug known as a "mRNA
vaccine" was created using cutting-edge technology with mRNA as the
genetic component. Due to their improved immunogenicity, greater potency, quick
development, relative affordability, and safety compared to conventional
vaccines, mRNA vaccines are a more effective alternative.
Global mRNA vaccines market is divided into COVID-19
mRNA vaccines and Non COVID-19 mRNA vaccines based on application. The COVID-19
mRNA vaccine experienced a significant rise during the COVID years, or
2021–2022, due to the worldwide prevalence of COVID virus. As the frequency of COVID
cases declines in comparison to pandemic years, the Non COVID-19 mRNA vaccines
will experience considerable growth during the prediction period.
North America, Europe, Asia Pacific, South
America, and Middle East & Africa are the regions into which the global
mRNA vaccine market can be divided. The global market for mRNA vaccines is
anticipated to be dominated by North America during the forecast period. The
market in North America is expected to be driven by a rise in demand for mRNA
vaccines for infectious or chronic diseases as well as the existence of major
players operating in the United States.
Major companies operating in Global mRNA Vaccines Market are:
- Arcturus
Therapeutics Holdings Inc.
- BioNTech SE
- CureVac N.V.
- Daiichi Sankyo
Company Limited.
- Ethris GmbH
- GlaxoSmithKline plc
- Gennova
Biopharmaceuticals Ltd
- Moderna, Inc.
- Pantherna
Therapeutics GmbH
- Providence
Therapeutics
- Silence
Therapeutics
- Translate Bio
- VERSAMEB AG
- Verve Therapeutics
Inc.
Pharmaceutical
companies are eager to invest more money in the production of mRNA-based COVID-19
vaccines because of the rise in COVID-19 cases and the government's increasing
emphasis on the establishment of effective immunization techniques.
Pharmaceutical companies are also making considerable investments to expand
their separate pipelines for non-COVID-19 applications such as infectious
illnesses, cancer, and other disorders as a result of the increased popularity
of mRNA vaccines. BioNTech SE has been a pioneer in the mRNA vaccines and
therapeutics ecosystem thanks to the presence of a diversified portfolio and
intense market penetration.
Download Free Sample Report
Customers can also request for 10% free customization on this report.
“mRNA
Vaccine market will witness robust growth during the forecast period owing to
the advancement of mRNA technologies to produce mRNA vaccines to prevent
infectious or chronic diseases. The prevalence of chronic disease will also
boost the growth of market. mRNA vaccines are the rapidly producing vaccine
comparative to other vaccines produced from biological means. Furthermore,
increasing research & development in the domain of vaccine production
through mRNA all over the world will also affect the market growth, positively.”
said Mr. Karan Chechi, Research Director with TechSci Research, a research
based global management consulting firm.
“mRNA
Vaccine Market- Global Industry Size, Share, Trends, Opportunity, and Forecast,
2018-2028, Segmented By mRNA Type
(Nucleoside-modified mRNA, Unmodified mRNA, Self-Amplifying mRNA), By
Application (COVID-19 mRNA Vaccines, Non COVID-19 mRNA Vaccines, Others),
Region and Competition”, has
evaluated the future growth potential of Global mRNA Vaccines Market and
provides statistics & information on market size, structure, and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global mRNA Vaccines Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com